Merck

TEMODAR

Manufacturer:

Merck

Temodar HCPCS:

J9328

HCPCS Code Descriptor:

Injection, temozolomide, 1 mg

Category:

J Code

Temodar NDCs:

00085-1381-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Temodar:

TEMODAR is an Oncology drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J9328 is aligned to the drug TEMODAR.

ACCESS PRICING AND MORE BY REGISTERING

J9328 Added Date:

January 1, 2010

J9328 Effective Date:

January 1, 2010

J9328 Termination Date:

HCPCS Active

Temodar billing and coding information can be found through Merck at the link below:
Temodar patient assistance information can be found through The Merck Patient Assistance Program at the URL: https://www.merck.com/patients/patient-financial-assistance/
TEMODAR prescribing information can be found at the link below:
Information regarding TEMODAR’s side effects can be found at MedlinePlus